Zacks lowers Surgery Partners' rating to 'strong sell': 3 quick notes

Zacks downgraded Surgery Partners shares from a "hold" to a "strong sell" Nov. 18, according to True Blue Tribune.

Here are three quick notes:

1. Bank of America recently reduced its price target on Surgery Partners' shares from $23 to $19.

2. Surgery Partners has a P/E ratio of 55.67.

3. The company's debt-to-equity ratio totals 1.56.